Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
l�ll
Critical illness neuromuscular disease: clinical, electrophysiological, and prognostic aspects Tabarki B; Coffinieres A; Van Den Bergh P; Huault G; Landrieu P; Sebire GArch Dis Child 2002[Feb]; 86 (2): 103-7BACKGROUND: Critical illness neuromuscular disease, which has been recognised as a distinct clinical entity in adults, remains poorly described in children. AIMS: To assess retrospectively the clinical, electrophysiological, and prognostic features of the disease. METHODS: Retrospective study in a children's university hospital. RESULTS: Five critically ill patients presented with generalised paralysis, associated with long lasting failure to breathe in three. The cause of the generalised paralysis was critical illness neuropathy in two, acute myopathy in two, and mixed neuromyopathy in one. CONCLUSIONS: Neuromuscular disease should be suspected in critically ill children with muscle weakness. Because corticosteroids and muscle relaxants appear to trigger some types of intensive care unit neuromuscular disease in children, their use should be restricted or administered at the lowest doses possible.|Adolescent[MESH]|Child[MESH]|Child, Preschool[MESH]|Critical Illness/*therapy[MESH]|Electromyography[MESH]|Electrophysiology[MESH]|Fatal Outcome[MESH]|Female[MESH]|Humans[MESH]|Male[MESH]|Neural Conduction/physiology[MESH]|Neuromuscular Diseases/etiology/*physiopathology[MESH]|Neuromuscular Nondepolarizing Agents/adverse effects[MESH]|Prognosis[MESH]|Retrospective Studies[MESH]|Vecuronium Bromide/adverse effects[MESH] |